Free Trial

Nomura Holdings Inc. Invests $547,000 in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background

Nomura Holdings Inc. bought a new position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,881 shares of the company's stock, valued at approximately $547,000.

A number of other hedge funds have also recently modified their holdings of the stock. NorthRock Partners LLC purchased a new stake in shares of Molina Healthcare in the fourth quarter worth about $206,000. Numerai GP LLC purchased a new stake in shares of Molina Healthcare in the fourth quarter worth about $395,000. Lazard Asset Management LLC boosted its stake in shares of Molina Healthcare by 19.1% in the fourth quarter. Lazard Asset Management LLC now owns 7,694 shares of the company's stock worth $2,239,000 after buying an additional 1,234 shares during the last quarter. Laird Norton Wetherby Wealth Management LLC boosted its stake in shares of Molina Healthcare by 7.1% in the fourth quarter. Laird Norton Wetherby Wealth Management LLC now owns 877 shares of the company's stock worth $255,000 after buying an additional 58 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its stake in shares of Molina Healthcare by 6.4% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 537,057 shares of the company's stock worth $156,310,000 after buying an additional 32,273 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

Molina Healthcare Price Performance

Shares of NYSE:MOH traded up $2.57 during midday trading on Tuesday, hitting $307.80. The company had a trading volume of 423,812 shares, compared to its average volume of 692,698. Molina Healthcare, Inc. has a twelve month low of $262.32 and a twelve month high of $365.23. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. The stock has a market cap of $16.68 billion, a price-to-earnings ratio of 15.07, a price-to-earnings-growth ratio of 1.06 and a beta of 0.63. The business's 50-day simple moving average is $324.10 and its 200-day simple moving average is $307.58.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating the consensus estimate of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The firm had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. During the same quarter last year, the firm earned $5.73 earnings per share. The business's revenue for the quarter was up 12.2% on a year-over-year basis. On average, research analysts predict that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on MOH shares. Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Robert W. Baird reaffirmed a "neutral" rating and issued a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Barclays upped their price target on Molina Healthcare from $339.00 to $362.00 and gave the stock an "equal weight" rating in a report on Friday, April 25th. Sanford C. Bernstein began coverage on Molina Healthcare in a report on Tuesday, April 22nd. They issued an "outperform" rating and a $414.00 price target for the company. Finally, UBS Group reduced their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a report on Friday, February 7th. Nine equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $365.38.

View Our Latest Research Report on MOH

Insider Activity at Molina Healthcare

In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of the company's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the transaction, the director now owns 11,244 shares of the company's stock, valued at $3,603,702. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. This represents a 5.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 89,169 shares of company stock valued at $28,520,995. 1.10% of the stock is currently owned by insiders.

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Recommended Stories

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines